Apple's watch is capable of monitoring heartbeat disorders, which may require greater monitoring of the possibility of a serious heart attack, according to data from a study sponsored by Apple Inc.
The huge study shows the potential role of technology devices in the healthcare sector in the future.
Researchers hope the technology will help in early monitoring of atrial fibrillation, the most common form of heartbeat disorder. The risk of stroke is five times higher than in others.
The results of the largest study to monitor and monitor atrial fibrillation and included more than 400 thousand users of Apple Clock on Saturday at the meeting of the American College of Cardiology in New Orleans.
Among the participants, 0.5 percent or about 2,000 participants received notifications of cardiac arrhythmias. EKGs were sent to this group to monitor any atrial fibrillation.
One third of the group was diagnosed with atrial fibrillation after using ECG, the researchers said.
The data showed that about 84 percent of troubled pulse notifications were later confirmed to be associated with atrial fibrillation.
"The doctor can use the information from the study and collect it with his assessment," said Dr. Marco Pérez, a researcher at the Stanford University School of Medicine and a co-author of the study. "Then he makes decisions about what to do with a notification."
The data represents a major boost for Apple as it seeks to enter the world of healthcare. Her new Ceres 4 watch, launched after the start of the study and was not used, has the possibility of a heart scan to monitor any problems and requires a license from the US Food and Drug Administration.